New clinical trial shows second generation drug-eluting stents are safe and effective

(Society for Cardiovascular Angiography and Interventions) Results of the PERSPECTIVE trial were presented today as late-breaking clinical science at the SCAI 2018 Scientific Sessions, and reports on one-year outcomes of patients undergoing CTO PCI treated with Zotarolimus-Eluting Stents (ZES).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news